Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David M Gershenson
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
248 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- El Camino Hospital
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
- Wilma Chan Highland Hospital
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Doctors Medical Center- Jc Robinson Regional Cancer Center
San Pablo, California, United States
- Olive View-University of California Los Angeles Medical Center
Sylmar, California, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Saint Joseph Hospital - Cancer Centers of Colorado
Denver, Colorado, United States
- Western States Cancer Research Ncorp
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Saint Mary'S Hospital and Regional Medical Center
Grand Junction, Colorado, United States
- Banner North Colorado Medical Center
Greeley, Colorado, United States
- Commonspirit Saint Anthony Hospital Cancer Center
Lakewood, Colorado, United States
- Adventhealth Littleton
Littleton, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Longmont United Hospital
Longmont, Colorado, United States
- Banner North Colorado Medical Center - Loveland Campus
Loveland, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Oct 2010
- Primary completion
- 25 Feb 2015
- Completion
- 12 Mar 2027
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 50
- Registry id
- NCT01081262
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.